Respiratory Effects of Silver and Carbon Nanomaterials (RESAC)

银和碳纳米材料的呼吸效应 (RESAC)

基本信息

  • 批准号:
    8675855
  • 负责人:
  • 金额:
    $ 86.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-28 至 2016-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Engineered nanomaterials (ENMs) have novel physical and chemical properties, stemming from their nanometer-scale size, and can undergo dynamic changes (e.g., agglomeration, aggregation, and oxidation) when interacting with biological systems. This interaction, thus, has important implications for ENM health effects. The proposed Center grant, entitled 'Respiratory Effects of Silver and Carbon Nanomaterials (RESAC)', focusing on the interaction between ENMs and the lung lining fluid, will use a systematic, integrated, multidisciplinary approach to produce mechanism-driven toxicological data that will be used in a mechanism-based risk analysis framework for ENMs. Main research of the Center will be carried out through three inter-related projects. Project 1 will use cell models to determine ENM physicochemical properties (e.g., size, shape, aspect ratio, chemistry) that dictate the molecular, cellular, and immune reactivities in response to ENM interactions with the lung lining fluid. It is expected that such interaction will also critically impact ENM physicochemical properties, which in turn, will impact on the ENM reactivity with macrophages and epithelial cells. These early cellular- and molecular-level events are crucial in predicting the ultimate fate and pathological consequences of inhaled ENMs, which will be studied in Project 2 using rat and mouse models. Project 2 will examine whether and how inhaled ENMs affect lung surfactant composition and function, induce lung inflammation and lung pathology, generate oxidative stress, penetrate lung cells, and affect the innate immune function of macrophages. Results generated from Projects 1 and 2, along with other relevant data to be collected, will be used in Project 3 that is to define, demonstrate, and test a prototype generalized risk analysis framework for ENMs by implementing, adapting, and expanding available state-of-the-art multi-scale modeling systems for the exposure-to-dose-to-effect sequence. Our new models will mathematically link specific ENM properties (e.g., surface area) to biological effects, allowing the use of most relevant 'dosimetry' in predicting ENM health risks.
描述(由申请人提供):工程纳米材料(ENM)具有源于其纳米级尺寸的新颖物理和化学性质,并且可以经历动态变化(例如,附聚、聚集和氧化)。因此,这种相互作用对ENM的健康影响具有重要意义。拟议的中心赠款,题为“呼吸影响的银和碳纳米材料(RESAC)”,重点是之间的相互作用ENM和肺衬里液,将使用系统的,综合的,多学科的方法来产生机制驱动的毒理学数据,将用于基于机制的风险分析框架ENM。该中心的主要研究将通过三个相互关联的项目进行。项目1将使用细胞模型来确定ENM的物理化学性质(例如,大小、形状、纵横比、化学性质),其决定了响应于ENM与肺衬里液的相互作用的分子、细胞和免疫反应性。预计这种相互作用也将严重影响ENM的物理化学性质,进而影响ENM与巨噬细胞和上皮细胞的反应性。这些早期细胞和分子水平的事件对于预测吸入ENM的最终命运和病理后果至关重要,这将在项目2中使用大鼠和小鼠模型进行研究。项目2将研究吸入ENM是否以及如何影响肺表面活性物质的组成和功能,诱导肺部炎症和肺部病理,产生氧化应激,穿透肺细胞,并影响巨噬细胞的先天免疫功能。项目1和2生成的结果以及沿着收集的其他相关数据将用于项目3,即通过实施、调整和扩展适用于剂量-效应序列的现有最先进多尺度建模系统,定义、证明和测试ENM的原型广义风险分析框架。我们的新模型将在数学上联系特定的ENM属性(例如,表面积)的生物效应,允许使用最相关的“剂量学”在预测ENM的健康风险。

项目成果

期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Multi-walled carbon nanotube length as a critical determinant of bioreactivity with primary human pulmonary alveolar cells.
  • DOI:
    10.1016/j.carbon.2014.06.033
  • 发表时间:
    2014-11-01
  • 期刊:
  • 影响因子:
    10.9
  • 作者:
    Sweeney, Sinbad;Berhanu, Deborah;Misra, Superb K.;Thorley, Andrew J.;Valsami-Jones, Eugenia;Tetley, Teresa D.
  • 通讯作者:
    Tetley, Teresa D.
Translocation of Functionalized Multi-Walled Carbon Nanotubes across Human Pulmonary Alveolar Epithelium: Dominant Role of Epithelial Type 1 Cells.
  • DOI:
    10.1021/acsnano.5b08218
  • 发表时间:
    2016-05-24
  • 期刊:
  • 影响因子:
    17.1
  • 作者:
    Ruenraroengsak P;Chen S;Hu S;Melbourne J;Sweeney S;Thorley AJ;Skepper JN;Shaffer MS;Tetley TD;Porter AE
  • 通讯作者:
    Porter AE
Aqueous cationic, anionic and non-ionic multi-walled carbon nanotubes, functionalised with minimal framework damage, for biomedical application.
  • DOI:
    10.1016/j.biomaterials.2014.02.002
  • 发表时间:
    2014-06
  • 期刊:
  • 影响因子:
    14
  • 作者:
    Chen, Shu;Hu, Sheng;Smith, Elizabeth F.;Ruenraroengsak, Pakatip;Thorley, Andrew J.;Menzel, Robert;Goode, Angela E.;Ryan, Mary P.;Tetley, Teresa D.;Porter, Alexandra E.;Shaffer, Milo S. P.
  • 通讯作者:
    Shaffer, Milo S. P.
Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epithelium.
  • DOI:
    10.1021/nn505399e
  • 发表时间:
    2014-11-25
  • 期刊:
  • 影响因子:
    17.1
  • 作者:
    Thorley, Andrew J.;Ruenraroengsak, Pakatip;Potter, Thomas E.;Tetley, Teresa D.
  • 通讯作者:
    Tetley, Teresa D.
High resolution and dynamic imaging of biopersistence and bioreactivity of extra and intracellular MWNTs exposed to microglial cells.
  • DOI:
    10.1016/j.biomaterials.2015.08.019
  • 发表时间:
    2015-11
  • 期刊:
  • 影响因子:
    14
  • 作者:
    Goode AE;Gonzalez Carter DA;Motskin M;Pienaar IS;Chen S;Hu S;Ruenraroengsak P;Ryan MP;Shaffer MS;Dexter DT;Porter AE
  • 通讯作者:
    Porter AE
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Teresa Dorothy Tetley其他文献

Teresa Dorothy Tetley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Teresa Dorothy Tetley', 18)}}的其他基金

Respiratory Effects of Silver and Carbon Nanomaterials (RESAC)
银和碳纳米材料的呼吸效应 (RESAC)
  • 批准号:
    8288360
  • 财政年份:
    2010
  • 资助金额:
    $ 86.1万
  • 项目类别:
Respiratory Effects of Silver and Carbon Nanomaterials (RESAC)
银和碳纳米材料的呼吸效应 (RESAC)
  • 批准号:
    8017605
  • 财政年份:
    2010
  • 资助金额:
    $ 86.1万
  • 项目类别:
Respiratory Effects of Silver and Carbon Nanomaterials (RESAC)
银和碳纳米材料的呼吸效应 (RESAC)
  • 批准号:
    8150920
  • 财政年份:
    2010
  • 资助金额:
    $ 86.1万
  • 项目类别:
Respiratory Effects of Silver and Carbon Nanomaterials (RESAC)
银和碳纳米材料的呼吸效应 (RESAC)
  • 批准号:
    8468709
  • 财政年份:
    2010
  • 资助金额:
    $ 86.1万
  • 项目类别:
Mechanisms of bioreactivity of engineered nanoparticles with pulmonary gas exchange barrier
具有肺气体交换屏障的工程纳米粒子的生物反应机制
  • 批准号:
    G0700926/1
  • 财政年份:
    2008
  • 资助金额:
    $ 86.1万
  • 项目类别:
    Research Grant
Respiratory sensitisation in humans: Characterisation of pulmonary epithelial:dendritic cell interactions
人类呼吸致敏:肺上皮的表征:树突状细胞相互作用
  • 批准号:
    BB/D018617/1
  • 财政年份:
    2006
  • 资助金额:
    $ 86.1万
  • 项目类别:
    Research Grant

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 86.1万
  • 项目类别:
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 86.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
  • 批准号:
    10677169
  • 财政年份:
    2023
  • 资助金额:
    $ 86.1万
  • 项目类别:
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells
桥粒斑蛋白对肺泡2型细胞肺纤维化的遗传贡献机制研究
  • 批准号:
    10736228
  • 财政年份:
    2023
  • 资助金额:
    $ 86.1万
  • 项目类别:
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
  • 批准号:
    10726763
  • 财政年份:
    2023
  • 资助金额:
    $ 86.1万
  • 项目类别:
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome
肝肺综合征低氧血症的新肺泡机制
  • 批准号:
    10718446
  • 财政年份:
    2023
  • 资助金额:
    $ 86.1万
  • 项目类别:
Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis
利用诱导多能干细胞研究肺泡2型细胞功能障碍在肺纤维化中的作用
  • 批准号:
    10591174
  • 财政年份:
    2023
  • 资助金额:
    $ 86.1万
  • 项目类别:
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling
酒精和电子烟通过嘌呤受体信号传导引起血脑和肺泡内皮屏障损伤
  • 批准号:
    10638221
  • 财政年份:
    2023
  • 资助金额:
    $ 86.1万
  • 项目类别:
Alveolar Epithelial Cell Dysfunction Induced By Flavored E-Cigarette Aerosols
加味电子烟气雾剂引起的肺泡上皮细胞功能障碍
  • 批准号:
    10770080
  • 财政年份:
    2023
  • 资助金额:
    $ 86.1万
  • 项目类别:
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease
描述let-7 microRNA对肺AT2细胞稳态、肺泡再生和间质性肺疾病的作用
  • 批准号:
    10634881
  • 财政年份:
    2023
  • 资助金额:
    $ 86.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了